全文获取类型
收费全文 | 166篇 |
免费 | 8篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 1篇 |
妇产科学 | 2篇 |
基础医学 | 11篇 |
口腔科学 | 17篇 |
临床医学 | 10篇 |
内科学 | 38篇 |
神经病学 | 24篇 |
特种医学 | 1篇 |
外科学 | 33篇 |
预防医学 | 13篇 |
药学 | 19篇 |
中国医学 | 2篇 |
肿瘤学 | 2篇 |
出版年
2021年 | 4篇 |
2020年 | 4篇 |
2019年 | 6篇 |
2018年 | 7篇 |
2017年 | 5篇 |
2016年 | 1篇 |
2015年 | 3篇 |
2014年 | 3篇 |
2013年 | 8篇 |
2012年 | 18篇 |
2011年 | 11篇 |
2010年 | 6篇 |
2009年 | 6篇 |
2008年 | 9篇 |
2007年 | 16篇 |
2006年 | 13篇 |
2005年 | 12篇 |
2004年 | 6篇 |
2003年 | 5篇 |
2002年 | 9篇 |
2001年 | 9篇 |
2000年 | 5篇 |
1999年 | 5篇 |
1998年 | 1篇 |
1992年 | 1篇 |
1985年 | 1篇 |
排序方式: 共有174条查询结果,搜索用时 31 毫秒
1.
2.
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group 总被引:34,自引:0,他引:34
McClung MR Geusens P Miller PD Zippel H Bensen WG Roux C Adami S Fogelman I Diamond T Eastell R Meunier PJ Reginster JY;Hip Intervention Program Study Group 《The New England journal of medicine》2001,344(5):333-340
BACKGROUND: Risedronate increases bone mineral density in elderly women, but whether it prevents hip fracture is not known. METHODS: We studied 5445 women 70 to 79 years old who had osteoporosis (indicated by a T score for bone mineral density at the femoral neck that was more than 4 SD below the mean peak value in young adults [-4] or lower than -3 plus a nonskeletal risk factor for hip fracture, such as poor gait or a propensity to fall) and 3886 women at least 80 years old who had at least one nonskeletal risk factor for hip fracture or low bone mineral density at the femoral neck (T score, lower than -4 or lower than -3 plus a hip-axis length of 11.1 cm or greater). The women were randomly assigned to receive treatment with oral risedronate (2.5 or 5.0 mg daily) or placebo for three years. The primary end point was the occurrence of hip fracture. RESULTS: Overall, the incidence of hip fracture among all the women assigned to risedronate was 2.8 percent, as compared with 3.9 percent among those assigned to placebo (relative risk, 0.7; 95 percent confidence interval, 0.6 to 0.9; P=0.02). In the group of women with osteoporosis (those 70 to 79 years old), the incidence of hip fracture among those assigned to risedronate was 1.9 percent, as compared with 3.2 percent among those assigned to placebo (relative risk, 0.6; 95 percent confidence interval, 0.4 to 0.9; P=0.009). In the group of women selected primarily on the basis of nonskeletal risk factors (those at least 80 years of age), the incidence of hip fracture was 4.2 percent among those assigned to risedronate and 5.1 percent among those assigned to placebo (P=0.35). CONCLUSIONS: Risedronate significantly reduces the risk of hip fracture among elderly women with confirmed osteoporosis but not among elderly women selected primarily on the basis of risk factors other than low bone mineral density. 相似文献
3.
José M. de la Torre Hernández Salvatore Brugaletta Joan A. Gómez Hospital José A. Baz Armando Pérez de Prado Ramón López Palop Belen Cid Tamara García Camarero Alejandro Diego Hipólito Gutiérrez José A. Fernández Diaz Juan Sanchis Fernando Alfonso Roberto Blanco Javier Botas Javier Navarro Cuartero José Moreu Francisco Bosa Antonio J. Domínguez 《Revista espa?ola de cardiología》2019,72(12):1005-1011
Background and objectivesPatients older than 75 years with ST-segment elevation myocardial infarction undergoing primary angioplasty in cardiogenic shock have high mortality. Identification of preprocedural predictors of short- and long-term mortality could be useful to guide decision-making and further interventions.MethodsWe analyzed a nationwide registry of primary angioplasty in the elderly (ESTROFA MI + 75) comprising 3576 patients. The characteristics and outcomes of the subgroup of patients in cardiogenic shock were analyzed to identify associated factors and prognostic predictors in order to derive a baseline risk prediction score for 1-year mortality. The score was validated in an independent cohort.ResultsA total of 332 patients were included. Baseline independent predictors of mortality were anterior myocardial infarction (HR 2.8, 95%CI, 1.4-6.0; P = .005), ejection fraction < 40% (HR 2.3, 95%CI, 1.14-4.50; P = .018), and time from symptom onset to angioplasty > 6 hours (HR 3.2, 95%CI, 1.6-7.5; P = .001). A score was designed that included these predictive factors (score “6-ANT-40”). Survival at 1 year was 54.5% for patients with score 0, 32.3% for score 1, 27.4% for score 2 and 17% for score 3 (P = .004, c-statistic 0.70). The score was validated in an independent cohort of 124 patients, showing 1-year survival rates of 64.5%, 40.0%, 28.9%, and 22.2%, respectively (P = .008, c-statistic 0.68).ConclusionsA preprocedural score based on 3 simple clinical variables (anterior location, ejection fraction < 40%, and delay time > 6 hours) may be used to estimate survival after primary angioplasty in elderly patients with cardiogenic shock and to guide preinterventional decision-making. 相似文献
4.
Ana G. Almeida Natália António Carla Saraiva António Miguel Ferreira António Hipólito Reis Hugo Marques Nuno Dias Ferreira Mário Oliveira 《Revista portuguesa de cardiologia》2021,40(1):41-52
Magnetic resonance imaging (MRI) is currently considered an essential complementary method for diagnosis in many conditions. Exponential growth in its use is expected due to the aging population and a broader spectrum of clinical indications. Growth in its use, coupled with an increasing number of pacemaker implants, implantable cardioverter‐defibrillators and cardiac resynchronization therapy, has led to a frequent clinical need for this diagnostic modality in patients with cardiac implantable electronic devices (CIED). This clinical need has fueled the development of devices specifically designed and approved for use in a magnetic resonance (MR) environment under certain safety conditions (MR‐conditional devices). More than a decade after the introduction of the first MR‐conditional pacemaker, there are now several dozen MR‐conditional devices with different safety specifications. In recent years, increasing evidence has indicated there is a low risk to MRI use in conventional (so‐called non‐MR‐conditional) CIED patients in the right circumstances. The increasing number, as well as the greater diversity and complexity of implanted devices, justify the need to standardize procedures, by establishing institutional agreements that require close collaboration between cardiologists and radiologists. This consensus document, prepared jointly by the Portuguese Society of Cardiology and the Portuguese Society of Radiology and Nuclear Medicine, provides general guidelines for MRI in patients with CIED, ensuring the safety of patients, health professionals and equipment. In addition to briefly reviewing the potential risks of MRI in patients with CIED and major changes to MRI‐conditional devices, this article provides specific recommendations on risk‐benefit analysis, informed consent, scheduling, programming strategies, devices, monitoring and modification of MRI sequences. The main purpose of this document is to optimize patient safety and provide legal support to facilitate easy access by CIED patients to a potentially beneficial and irreplaceable diagnostic technique. 相似文献
5.
6.
Hipólito Nzwalo Vera Santos Cátia Gradil José Pedro Vieira Carla Mendonça 《Pediatric neurology》2013,48(3):240-243
Moyamoya disease is an idiopathic progressive steno-occlusive disorder of the intracranial arteries located at the base of the brain. It is associated with the development of compensatory extensive network of fine collaterals. Moyamoya disease is considered syndromic when certain genetic or acquired disorders such as polycystic kidney disease, neurofibromatosis, or meningitis are also present. Although the genetic contribution in moyamoya is indisputable, its cause and pathogenesis remain under discussion. Herein, we report a rare occurrence of moyamoya syndrome in two European Caucasian siblings in association with unusual multisystemic malformations (polycystic kidney disease in one, and intestinal duplication cyst in the other). The karyotype was normal. No mutation in the RFN213 gene was found, and none of the HLA types linked to moyamoya disease or described in similar familial cases were identified. By describing these multisystemic associations, polycystic kidney disease for the second time, and intestinal malformation for the first time in the literature, our report expands the phenotypic variability of moyamoya syndrome. The coexistence of disparate malformations among close relatives suggests an underlying common genetic background predisposing to structural or physiological abnormalities in different tissues and organs. 相似文献
7.
8.
Satvinder Kaur Hip Seng Yim Rohana Abdul Jalil Barakatun-Nisak Mohd-Yusof Hamid Jan. Jan Mohamed 《Journal of immigrant and minority health / Center for Minority Public Health》2018,20(6):1380-1386
There are only limited reports on Punjabi’s health status in Malaysia. This cross-sectional study assessed the prevalence of metabolic syndrome (Mets) and its risk factors among 277 subjects recruited from the Malaysian Punjabi community. Overall prevalence of Mets was 43%, but 61% among females. Subjects classified with Mets had significantly (p?<?0.05) higher body mass index, visceral fat and percentage of body fat. Daily carbohydrate and glycemic index (GI) were also higher among Mets subjects (p?<?0.05). Logistics regression analysis showed that primary level of education (OR 5.57, CI 1.29–23.97, p?=?0.021) was a factor associated with Mets, followed by middle household income (OR 2.30, CI 1.01–5.20, p?=?0.046), GI (OR 1.03, CI 1.00–1.06, p?=?0.026), and age (OR 1.03, CI 1.00–1.05, p?=?0.023). Mets shows high prevalence among the studied Punjabi population, prompting the consideration of adequate preventive measures, primarily among lower socioeconomic groups. 相似文献
9.
Conceição C Van Lerberghe W Ramos V Hipólito F Ferrinho P 《Cahiers de sociologie et de démographie médicales》2007,47(3):293-313
In Portugal, the design and the implementation of models of primary care teams has a history of 30 years. The evolution observed is from individual medical work, in Health Centres, supported on an ad hoc basis by other health professionals, to health centres integrating a diversity of formal working groups, including primary care/family health teams called "Family Health Units" (FHU). This evolution included the creation and gradual affirmation of the speciality of family medicine and the experimentation with different models of primary health care provision: voluntary primary care health teams without financial incentives (Alfa project), voluntary primary care health teams with a performance-related-remuneration system and the current phase of scaling up FHU. The process described here illustrates how a group of physicians has established a non-formal strategy of reform throughout 30 years. This strategy involves mobilization policies and the development of field experiences by individual leaders, groups and organizations. 相似文献
10.